 Economics, Pharmaceutical
"Economics, Pharmaceutical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. (From J Res Pharm Econ 1989;1(1); PharmacoEcon 1992;1(1))
| Descriptor ID |
D017850
|
| MeSH Number(s) |
N03.219.390
|
| Concept/Terms |
Pharmacy Economics- Pharmacy Economics
- Economic, Pharmacy
- Economics, Pharmacy
- Pharmacy Economic
|
Below are MeSH descriptors whose meaning is more general than "Economics, Pharmaceutical".
Below are MeSH descriptors whose meaning is more specific than "Economics, Pharmaceutical".
This graph shows the total number of publications written about "Economics, Pharmaceutical" by people in this website by year, and whether "Economics, Pharmaceutical" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2005 | 0 | 2 | 2 | | 2006 | 1 | 0 | 1 | | 2008 | 0 | 1 | 1 | | 2012 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 | | 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Economics, Pharmaceutical" by people in Profiles.
-
Alefan Q, Hamdouni E, Alhamad H, Mukattash T, Rascati K. Barriers to implementing pharmacoeconomics: interview study. Expert Rev Pharmacoecon Outcomes Res. 2021 Feb; 21(1):93-104.
-
Kang SY, Bai G, DiStefano MJ, Socal MP, Yehia F, Anderson GF. Comparative Approaches to Drug Pricing. Annu Rev Public Health. 2020 04 02; 41:499-512.
-
Kang SY, DiStefano MJ, Socal MP, Anderson GF. Using External Reference Pricing In Medicare Part D To Reduce Drug Price Differentials With Other Countries. Health Aff (Millwood). 2019 05; 38(5):804-811.
-
Alefan Q, Rascati K. PHARMACOECONOMIC STUDIES IN WORLD HEALTH ORGANIZATION EASTERN MEDITERRANEAN COUNTRIES: REPORTING COMPLETENESS. Int J Technol Assess Health Care. 2017 Jan; 33(2):215-221.
-
Dilokthornsakul P, McQueen RB, Chaiyakunapruk N, Spackman E, Watanabe JH, Campbell JD. Value of Information in Asia: Concepts, Current Use, and Future Directions. Value Health Reg Issues. 2016 May; 9:99-104.
-
Makhinova T, Rascati K. Pharmacoeconomics education in US colleges and schools of pharmacy. Am J Pharm Educ. 2013 Sep 12; 77(7):145.
-
Gavaza P, Rascati KL, Oladapo AO, Khoza S. The authors' reply to Gow et al.: "the state of health economic research in South Africa". Pharmacoeconomics. 2013 Mar; 31(3):255-6.
-
Gavaza P, Rascati KL, Oladapo AO, Khoza S. The state of health economic research in South Africa: a systematic review. Pharmacoeconomics. 2012 Oct 01; 30(10):925-40.
-
Desai PR, Chandwani HS, Rascati KL. Assessing the quality of pharmacoeconomic studies in India: a systematic review. Pharmacoeconomics. 2012 Sep 01; 30(9):749-62.
-
Slejko JF, Libby AM, Nair KV, Valuck RJ, Campbell JD. Pharmacoeconomics and outcomes research degree-granting PhD programs in the United States. Res Social Adm Pharm. 2013 Jan-Feb; 9(1):108-13.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|